Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence

Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence

Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment of malignant and non-malignant disorders. CARs are synthetic transmembrane receptors expressed on genetically modified immune effector cells, including T cells, natural killer (NK) cells, or macrophages, which are able t...

Full description

Bibliographic Details
Main Authors: Agata Czaplicka, Mieszko Lachota, Leszek Pączek, Radosław Zagożdżon, Beata Kaleta
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cells
Subjects:
adoptive cell therapy
CAR T cells
chimeric antigen receptor
immunotherapy
pancreatic cancer
Online Access:https://www.mdpi.com/2073-4409/13/1/101

Similar Items

Similar Items